Company
Sensible Biotechnologies
THE FIRST CELL-BASED mRNA THERAPEUTICS PLATFORM
Also known as Sensible Biotechnologies, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Sensible Biotechnologies, Inc.
Claim, correct or request removal
Record updated 19 October 2026
About
Synthetic mRNA has reached its limits. Our cell-based mRNA design and manufacturing platform enables pure, low immunogenicity mRNA that unlocks a new era of design-based biology.
Funding snapshot
- Total raised
- $1.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $13.5M2026-08-17
Funding rounds
- Round, 2026
- $13.5M2026-08-17, SEC form D sold
- Round, 2023
- $1.8M2023-02-06, SEC form D sold, 18 investors
Products
- Other
- cell-based mRNA design and manufacturing platform
Loading relationship preview